All Stories

  1. Prognostic value of ventilatory efficiency in hypersensitivity pneumonitis
  2. Challenges in harmonising terms and patterns among interstitial pneumonias: enter idiopathic bronchiolocentric interstitial pneumonia
  3. Baseline and Change in Peripheral Blood Transcriptome Enhance Outcome Prediction in Fibrotic Hypersensitivity Pneumonitis: A Prospective Multicenter Cohort Study
  4. One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease
  5. Monocyte Subset Predict Clinical Outcomes in Fibrotic Hypersensitivity Pneumonitis
  6. Psychometric Properties and Prognostic Value of the UCSD Shortness of Breath Questionnaire in Hypersensitivity Pneumonitis: A Prospective Cohort Study
  7. Rethinking the CT and Histopathological Nomenclature of Hypersensitivity Pneumonitis: Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia
  8. Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease
  9. Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren’s Patients Reveals Interferon Signature
  10. Alternative assays for identifying the inciting antigen in hypersensitivity pneumonitis
  11. Rationale and design of the prognostic transcriptomic signature in fibrotic hypersensitivity pneumonitis (PREDICT) study
  12. Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety
  13. Uncovering the Risk of Inhalational Exposures Across Interstitial Lung Diseases
  14. Prognostic accuracy of a peripheral blood transcriptome signature in chronic hypersensitivity pneumonitis
  15. Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report − Executive Summary
  16. Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
  17. Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop Report
  18. In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs
  19. Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
  20. Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases
  21. Soldiering on the Job When Ill: Productivity Costs in Connective Tissue Disease–associated Interstitial Lung Disease
  22. IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis
  23. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
  24. Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA
  25. Clinical Decision-Making in Hypersensitivity Pneumonitis: Diagnosis and Management
  26. Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
  27. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
  28. Trends in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis-Related Mortality in the United States, 1999 to 2017
  29. Reply to Hall et al.: Hypersensitivity Pneumonitis Mortality by Industry and Occupation
  30. Are Rural Residence and Poverty Independent Risk Factors for Chronic Obstructive Pulmonary Disease in the United States?
  31. Increasing Hypersensitivity Pneumonitis–related Mortality in the United States from 1988 to 2016
  32. The Role of Computed Tomography Honeycombing in Profiling Disease Progression in Chronic Interstitial Lung Disease
  33. Changing trends in age-adjusted pulmonary fibrosis mortality in the USA: a joinpoint regression analysis
  34. United States trends in mortality rates for primary immunodeficiency diseases
  35. IPF Look-Alikes
  36. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
  37. Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus Statement
  38. Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey
  39. Epidemiology of Hypersensitivity Pneumonitis among an Insured Population in the United States: A Claims-based Cohort Analysis
  40. An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis
  41. Presence of Air Trapping and Mosaic Attenuation on Chest Computed Tomography Predicts Survival in Chronic Hypersensitivity Pneumonitis
  42. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
  43. Refining the Burden of Idiopathic Pulmonary Fibrosis: The Cocktail Party Effect
  44. High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival
  45. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease
  46. Current Approach to Diagnosis and Management of Pulmonary Eosinophilic Syndromes: Eosinophilic Pneumonias, Eosinophilic Granulomatosis with Polyangiitis, and Hypereosinophilic Syndrome
  47. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
  48. Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis
  49. Fibrotic hypersensitivity pneumonitis
  50. Pulmonary Function and Survival in Idiopathic vs Secondary Usual Interstitial Pneumonia
  51. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
  52. Nonasthmatic Eosinophilic Bronchitis
  53. Bronchiectasis
  54. Eosinophilic Lung Diseases
  55. Identifying an Inciting Antigen Is Associated With Improved Survival in Patients With Chronic Hypersensitivity Pneumonitis
  56. FEV1 over time in patients with connective tissue disease-related bronchiolitis
  57. Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
  58. Granulomatous Lymphocytic Interstitial Lung Disease
  59. Peeling away the layers of the volume-outcome effect and harvesting hidden connections*
  60. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease
  61. Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease
  62. Rheumatoid Arthritis and Pneumoconiosis
  63. Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death
  64. Air hunger, unwelcome guests, clogged pipes and idiopathic inflammatory myositis: Can we do better?
  65. Interpretation of airway pressure waveforms
  66. Eosinophilic Lung Diseases
  67. Increased Risk of Pulmonary Embolism Among US Decedents With Sarcoidosis From 1988 to 2007
  68. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
  69. Derivation and Diagnostic Accuracy of the Surgical Lung Injury Prediction Model
  70. Sarcoidosis-related Mortality in the United States from 1988 to 2007
  71. Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
  72. Rheumatoid Arthritis–Interstitial Lung Disease–associated Mortality
  73. Long-Term Survival and Quality of Life After Transfusion-Associated Pulmonary Edema in Critically III Medical Patients
  74. Severity of Illness and Outcome in Patients With End-Stage Idiopathic Pulmonary Fibrosis Requiring Mechanical Ventilation: Response
  75. Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis
  76. Outcome of critically ill patients with influenza virus infection
  77. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
  78. Heart Rate Recovery After 6-Min Walk Test Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis
  79. Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study
  80. Respiratory Monitoring
  81. Interpretation of airway pressure waveforms
  82. Ventilator Settings and Outcome of Respiratory Failure in Chronic Interstitial Lung Disease
  83. The Practice of Platelet Transfusion in the Intensive Care Unit
  84. The addition of decision support into computerized physician order entry reduces red blood cell transfusion resource utilization in the intensive care unit
  85. Nonfamilial hemophagocytic lymphohistiocytosis
  86. Post-thoracentesis trapped lung
  87. Acute pancreatitis due to hereditary angioedema
  88. Transfusion‐related acute lung injury and pulmonary edema in critically ill patients: a retrospective study
  89. Intraoperative Tidal Volume as a Risk Factor for Respiratory Failure after Pneumonectomy
  90. A case of hydrocortisone desensitization in a patient with radiocontrast-induced anaphylactoid reaction and corticosteroid allergy
  91. Interpretation of airway pressure waveforms
  92. Sepsis during pregnancy
  93. Interpretation of airway pressure waveforms